About the Role
We are seeking a Chief Scientific Officer (CSO) to lead the development of a scientific framework for brain-state transitions grounded in Landau–Ginzburg phase-transition phenomenology. Working closely with the founder, the CSO will connect theoretical neuroscience, computational modeling, and experimental research to investigate applications in insomnia, PTSD, Alzheimer’s disease, Parkinson’s disease, and other neurological and neuropsychiatric conditions. The role will translate testable models of brain dynamics into biomarkers and noninvasive sensory neuromodulation protocols, guiding the scientific program from foundational research through clinical validation.
Key Responsibilities
- - Define and lead the scientific strategy, research roadmap, and experimental priorities for understanding and modulating brain-state transitions.
- - Develop and test Landau–Ginzburg and related dynamical models of healthy and pathological brain states, including candidate order parameters, control parameters, stability, and transition mechanisms.
- - Investigate electrophysiological biomarkers of prodromal stages of neurodegeneration in general and AD in particular.
- - Translate theoretical predictions into measurable hypotheses, electrophysiological biomarkers, and reproducible experimental studies.
- - Investigate the relevance of brain-state transition mechanisms to insomnia, PTSD, Alzheimer’s disease, Parkinson’s disease, and other priority indications.
- - Design and optimize sensory neuromodulation protocols, including auditory, visual, other somatosensory stimulation, and combined stimulation, to facilitate targeted brain-state transitions.
- - Guide the development of personalized and closed-loop stimulation approaches informed by EEG and other physiological measurements.
- - Oversee study design, data analysis, and interpretation, establishing rigorous standards for reproducibility, safety, and scientific claims.
- - Build and lead an interdisciplinary team and establish collaborations with academic researchers, clinicians, and clinical research centers.
- - Partner with engineering, clinical, and regulatory teams to translate research findings into device capabilities and clinical development plans.
- - Lead in developing nondilutive funding sources.
- - Assist in fundraising by presenting the underlying science behind our technology.
- - Lead scientific publications, grant proposals, and intellectual property development, and communicate the scientific program to partners and investors.
Requirements
- - PhD, MD/PhD, or equivalent research qualifications in neuroscience, physics, applied mathematics, biomedical engineering, or a closely related discipline.
- - Strong expertise in theoretical or computational neuroscience, with demonstrated ability to connect mathematical models to biological measurements.
- - Deep understanding of statistical physics, nonlinear dynamics in complex systems, and phase-transition theory, including Landau–Ginzburg phenomenology or closely related approaches.
- - A strong publication record demonstrating original research, scientific rigor, and independent thought.
- - Experience designing or leading experimental studies involving EEG, MEG, electrophysiology, neuroimaging, or other measures of brain dynamics.
- - Proficiency in computational modeling, neural time-series analysis, signal processing, statistical inference, and scientific programming.
- - Demonstrated ability to lead interdisciplinary research, mentor scientists, manage collaborations, and set achievable scientific milestones.
- - Ability to critically evaluate novel hypotheses, distinguish model predictions from established findings, and revise research directions as evidence develops.
- - Strong scientific writing and communication skills, including experience with publications, grant proposals, and presentations to diverse audiences.
- - Experience in sensory neuromodulation, neural entrainment, sleep research, or neurological and neuropsychiatric disorders is preferred.
- - Experience translating research into clinical studies or medical devices, particularly within a startup or industry setting, is preferred.
Nice to Have
- - Research experience applying Landau–Ginzburg theory, critical phenomena, metastability, or stochastic dynamics to biological systems.
- - Experience studying sleep-stage transitions, neural entrainment, or changes in brain-network dynamics.
- - Experience developing auditory, visual, or multisensory stimulation protocols.
- - Experience designing personalized or closed-loop neuromodulation using real-time EEG feedback.
- - Research experience in insomnia, PTSD, Alzheimer’s disease, Parkinson’s disease, or related conditions.
- - A track record of securing research grants, particularly through NIH, NSF, ARPA-H, or SBIR/STTR programs.
- - Experience translating scientific discoveries into patents, medical devices, or clinical research programs.
- - Experience in an early-stage company and an established network of academic and clinical collaborators.
About NeuroLight, Inc.
NeuroLight is addressing impaired brain-state transitions, beginning with disrupted sleep architecture—a major, under-addressed contributor to cognitive decline and neurodegeneration. We model the brain as a complex nonlinear dynamical system and sleep architecture as a sequence of state transitions, including phase-like transitions between wakefulness, N1, N2, slow-wave sleep, and REM. Our first product, NeuroMask™, is a noninvasive, EEG-guided, closed-loop neuromodulation wearable in a sleep-mask form factor. It uses precisely timed auditory and photic sensory stimulation to help the brain transition into restorative sleep states, especially slow-wave sleep. Grounded in nonlinear systems theory, the platform is designed to restore healthy sleep architecture and, over time, open a broader path to managing brain states for brain health. Our first commercial wedge is sleep, wellness, and longevity. Our North Star is the prevention of Alzheimer’s disease and other forms of neurodegeneration by restoring slow-wave sleep and supporting glymphatic clearance. NeuroLight has developed a beta prototype and was awarded a grant from the National Science Foundation. The company is led by a physicist and neuroscientist, a serial entrepreneur with multiple exits, and is protected by a strong intellectual-property moat.
- HQ
- Pomona, New York
- Team
- 1–10
- Founded
- 2017
- Last round
- Phase I NSF/SBIR Grant
Why Join
- Pioneering brain-state transition control NeuroLight is pioneering a transition-centered approach to neuromodulation.
- Physics-Based Neuromodulation: Our approach is grounded in nonlinear dynamics and Landau–Ginzburg phase-transition theory.
- Wearable, EEG-guided, closed-Loop brain-state navigation and neuromodulation
- Noninvasive multi-modal sensory brain stimulation using a combination of auditory and photic stimulation
Benefits
- - Stock options offering the opportunity to participate in the company’s future growth.
- - No salary or other cash compensation is currently paid; cash compensation is deferred until our first capital raise (seed round), with a separate opportunity for grant-funded employment.
- - Competitive salary and benefits following successful completion of the seed round.
- - Participation in grant applications, with a transition onto grant-funded payroll once an application supporting the role is funded.
- - The opportunity to work directly with the founder to shape the scientific vision, research priorities, and development of sensory neuromodulation technologies.
- - Scientific leadership at the intersection of neuroscience, physics, and medicine, with opportunities to lead publications, develop intellectual property, and build an interdisciplinary research team.
Skills & Tech
Ready to Apply?
Create your free profile to apply and see your personalized profile match for this role.
Apply NowSimilar Corporate functions roles elsewhere
General CounselMindful Health Solutions · Hybrid (New york, New York, US) · posted 13d ago
Head of PeopleMindful Health Solutions · Remote (United States) · posted 23d ago
Chief of Staff, CEOCeribell · Sunnyvale, CA · posted 1mo ago
Analyst I Postmarket SurveillanceAbbott Neuromodulation · United States - Texas - Plano · posted 3d ago
Corporate & Intellectual Property ParalegalCognito Therapeutics · Cambridge, MA - Hybrid · posted 4d ago
More at NeuroLight, Inc. (1)
Know someone perfect for this role?
Share this opportunity with your network